A detailed history of Envestnet Asset Management Inc transactions in Twist Bioscience Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 35,854 shares of TWST stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,854
Previous 29,839 20.16%
Holding current value
$1.32 Million
Previous $1.47 Million 10.14%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$36.72 - $58.88 $220,870 - $354,163
6,015 Added 20.16%
35,854 $1.62 Million
Q2 2024

Aug 08, 2024

BUY
$27.95 - $53.0 $157,861 - $299,344
5,648 Added 23.35%
29,839 $1.47 Million
Q1 2024

May 13, 2024

BUY
$32.28 - $41.5 $258,078 - $331,792
7,995 Added 49.36%
24,191 $829,000
Q4 2023

Feb 13, 2024

BUY
$15.08 - $38.61 $2,081 - $5,328
138 Added 0.86%
16,196 $596,000
Q3 2023

Nov 13, 2023

SELL
$18.62 - $26.57 $610,698 - $871,442
-32,798 Reduced 67.13%
16,058 $325,000
Q2 2023

Aug 04, 2023

SELL
$11.49 - $20.46 $84,715 - $150,851
-7,373 Reduced 13.11%
48,856 $999,000
Q1 2023

May 11, 2023

BUY
$14.6 - $30.9 $458,089 - $969,518
31,376 Added 126.25%
56,229 $847,000
Q4 2022

Feb 07, 2023

BUY
$21.92 - $39.37 $142,063 - $255,156
6,481 Added 35.28%
24,853 $591,000
Q3 2022

Nov 10, 2022

BUY
$33.44 - $56.56 $203,716 - $344,563
6,092 Added 49.61%
18,372 $647,000
Q2 2022

Aug 03, 2022

BUY
$26.2 - $54.0 $167,156 - $344,520
6,380 Added 108.14%
12,280 $429,000
Q1 2022

May 04, 2022

BUY
$38.58 - $83.27 $102,352 - $220,915
2,653 Added 81.71%
5,900 $291,000
Q4 2021

Feb 04, 2022

BUY
$75.47 - $135.88 $245,051 - $441,202
3,247 New
3,247 $251,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.08B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.